Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy - Evidence for a dominant negative action

被引:114
作者
Watkins, H
Seidman, CE
Seidman, JG
Feng, HS
Sweeney, HL
机构
[1] UNIV PENN, SCH MED, DEPT PHYSIOL, PHILADELPHIA, PA 19104 USA
[2] UNIV OXFORD, DEPT CARDIOVASC MED, OXFORD OX3 9DU, ENGLAND
[3] BRIGHAM & WOMENS HOSP, HOWARD HUGHES MED INST, BOSTON, MA 02115 USA
[4] BRIGHAM & WOMENS HOSP, DIV CARDIOVASC, BOSTON, MA 02115 USA
[5] HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA
[6] HOWARD HUGHES MED INST, BOSTON, MA 02115 USA
关键词
hypertrophic cardiomyopathy; troponin T; contractility; cardiac muscle; cardiac mechanics;
D O I
10.1172/JCI119063
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Mutations in the beta-myosin heavy chain gene are believed to cause hypertrophic cardiomyopathy (HCM) by acting as dominant negative alleles. In contrast, a truncated cardiac troponin T (TnT) that causes HCM implies that altered stoichiometry of contractile proteins may also cause cardiac hypertrophy. Wild-type and HCM-mutant (truncated) TnT were studied in a novel quail myotube expression system, Unexpectedly, antibody staining demonstrated incorporation of both forms of human cardiac TnT into the sarcomeres of quail myotubes, Functional studies of wild type and mutant transfected myotubes of normal appearance revealed that calcium-activated force of contraction was normal upon incorporation of wild type TnT, but greatly diminished for the mutant TnT, These findings indicate that HCM-causing mutations in TnT and beta-myosin heavy chain share abnormalities in common, acting as dominant negative alleles that impair contractile performance. This diminished force output is the Likely stimulus for hypertrophy in the human heart.
引用
收藏
页码:2456 / 2461
页数:6
相关论文
共 20 条
[1]   FUNCTIONS OF THE MYOSIN ATP AND ACTIN BINDING-SITES ARE REQUIRED FOR C-ELEGANS THICK FILAMENT ASSEMBLY [J].
BEJSOVEC, A ;
ANDERSON, P .
CELL, 1990, 60 (01) :133-140
[2]   CARDIAC MYOSIN BINDING PROTEIN-C GENE SPLICE ACCEPTOR SITE MUTATION IS ASSOCIATED WITH FAMILIAL HYPERTROPHIC CARDIOMYOPATHY [J].
BONNE, G ;
CARRIER, L ;
BERCOVICI, J ;
CRUAUD, C ;
RICHARD, P ;
HAINQUE, B ;
GAUTEL, M ;
LABEIT, S ;
JAMES, M ;
BECKMANN, J ;
WEISSENBACH, J ;
VOSBERG, HP ;
FISZMAN, M ;
KOMAJDA, M ;
SCHWARTZ, K .
NATURE GENETICS, 1995, 11 (04) :438-440
[3]   REGULATION OF CARDIAC GENE-EXPRESSION DURING MYOCARDIAL GROWTH AND HYPERTROPHY - MOLECULAR STUDIES OF AN ADAPTIVE PHYSIOLOGICAL-RESPONSE [J].
CHIEN, KR ;
KNOWLTON, KU ;
ZHU, H ;
CHIEN, S .
FASEB JOURNAL, 1991, 5 (15) :3037-3046
[4]   SKELETAL-MUSCLE EXPRESSION AND ABNORMAL FUNCTION OF BETA-MYOSIN IN HYPERTROPHIC CARDIOMYOPATHY [J].
CUDA, G ;
FANANAPAZIR, L ;
ZHU, WS ;
SELLERS, JR ;
EPSTEIN, ND .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2861-2865
[5]  
DAVIES MJ, 1984, BRIT HEART J, V51, P361
[6]   A MOLECULAR-BASIS FOR FAMILIAL HYPERTROPHIC CARDIOMYOPATHY - A BETA-CARDIAC MYOSIN HEAVY-CHAIN GENE MISSENSE MUTATION [J].
GEISTERFERLOWRANCE, AAT ;
KASS, S ;
TANIGAWA, G ;
VOSBERG, HP ;
MCKENNA, W ;
SEIDMAN, CE ;
SEIDMAN, JG .
CELL, 1990, 62 (05) :999-1006
[7]   ABNORMAL CONTRACTILE PROPERTIES OF MUSCLE-FIBERS EXPRESSING BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY [J].
LANKFORD, EB ;
EPSTEIN, ND ;
FANANAPAZIR, L ;
SWEENEY, HL .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (03) :1409-1414
[8]   ELECTRON-MICROSCOPIC AND ELECTROPHORETIC STUDIES OF A DROSOPHILA MUSCLE MUTANT WINGS-UP-B [J].
MOGAMI, K ;
NONOMURA, Y ;
HOTTA, Y .
JAPANESE JOURNAL OF GENETICS, 1981, 56 (01) :51-65
[9]   A MYOSIN MISSENSE MUTATION, NOT A NULL ALLELE, CAUSES FAMILIAL HYPERTROPHIC CARDIOMYOPATHY [J].
NISHI, H ;
KIMURA, A ;
HARADA, H ;
KOGA, Y ;
ADACHI, K ;
MATSUYAMA, K ;
KOYANAGI, T ;
YASUNAGA, S ;
IMAIZUMI, T ;
TOSHIMA, H ;
SASAZUKI, T .
CIRCULATION, 1995, 91 (12) :2911-2915
[10]  
PARKER TG, 1991, ANNU REV PHYSIOL, V53, P179